Company profile
Home :: Immunocore
Immunocore Limited is a UK company with status active founded in 2007 based in South East England.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
MR04 | Transaction MzQ0MzQ1OTU3MGFkaXF6a2N4
Published 14 Nov 2024 06:56
MR04 | Transaction MzQ0MzQ1OTU1MmFkaXF6a2N4
Published 14 Nov 2024 06:55
MR04 | Transaction MzQ0MzQ1OTUyN2FkaXF6a2N4
Published 14 Nov 2024 06:54
MR04 | Transaction MzQ0MzQ1ODQxOGFkaXF6a2N4
Published 14 Nov 2024 06:11
MR04 | Transaction MzQ0MzQ1ODM5MmFkaXF6a2N4
Published 14 Nov 2024 06:10
Company registered at Companies House
1 Oct 2013 to 30 Sep 2016
Immunocore has developed a new class of biologic drug called ImmTACs. ImmTACs are highly novel because they recognise intracellular changes in cancerous cells and can therefore be used to treat diseases, such as prostate cancer, that are not currently ammenable to targeted biological therapies. Targeted therapies represent a significant advance over tradi...
